Genetically engineered human neural stem cells for brain repair in neurological diseases
- PMID: 17303360
- DOI: 10.1016/j.braindev.2006.07.012
Genetically engineered human neural stem cells for brain repair in neurological diseases
Abstract
Neural stem cells (NSCs)of the central nervous system (CNS) have recently received a great deal of attention and interest for their therapeutic potential for neurological disorders. NSCs are defined as CNS progenitor cells that have the capacity for self-renewal and multipotent potential to become neurons or glial cells. Recent studies have shown that NSCs isolated from mammalian CNS including human can be propagated in vitro and then implanted into the brain of animal models of human neurological disorders. Recently, we have generated clonally derived immortalized human NSC cell lines via a retroviral vector encoded with v-myc oncogene. One of the human NSC lines, HB1.F3, was utilized in stem-cell based therapy in animal models of human neurological disorders. When F3 human NSCs were implanted into the brain of murine models of lysosomal storage diseases, stroke, Parkinson disease, Huntington disease or stroke, implanted F3 NSCs were found to migrate to the lesion sites, differentiate into neurons and glial cells, and restore functional deficits found in these neurological disorders. In animal models of brain tumors, F3 NSCs could deliver a bioactive therapeutically relevant molecules to effect a significant anti-tumor response intracranial tumor mass. Since these genetically engineered human NSCs are immortalized and continuously multiplying, there would be limitless supply of human neurons for treatment for patients suffering from neurological disorders including stroke, Parkinson disease, Huntington disease, ALS, multiple sclerosis and spinal cord injury. The promising field of stem cell research as it applies to regenerative medicine is still in infancy, but its potential appears limitless, and we are blessed to be involved in this exciting realm of research.
Similar articles
-
Brain transplantation of immortalized human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model.Stem Cells. 2007 May;25(5):1204-12. doi: 10.1634/stemcells.2006-0409. Epub 2007 Jan 11. Stem Cells. 2007. PMID: 17218400
-
Human neural stem cells overexpressing glial cell line-derived neurotrophic factor in experimental cerebral hemorrhage.Gene Ther. 2009 Sep;16(9):1066-76. doi: 10.1038/gt.2009.51. Epub 2009 Jun 25. Gene Ther. 2009. PMID: 19554035
-
Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse.J Neurosci Res. 2003 Oct 15;74(2):266-77. doi: 10.1002/jnr.10764. J Neurosci Res. 2003. PMID: 14515356
-
Stem cell-based cell therapy in neurological diseases: a review.J Neurosci Res. 2009 Aug 1;87(10):2183-200. doi: 10.1002/jnr.22054. J Neurosci Res. 2009. PMID: 19301431 Review.
-
Stem-cell based therapies for brain tumors.Curr Opin Mol Ther. 2008 Aug;10(4):334-42. Curr Opin Mol Ther. 2008. PMID: 18683097 Review.
Cited by
-
Contact and encirclement of glioma cells in vitro is an intrinsic behavior of a clonal human neural stem cell line.PLoS One. 2012;7(12):e51859. doi: 10.1371/journal.pone.0051859. Epub 2012 Dec 11. PLoS One. 2012. PMID: 23240066 Free PMC article.
-
Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.Mol Neurobiol. 2018 Apr;55(4):3152-3171. doi: 10.1007/s12035-017-0566-7. Epub 2017 May 2. Mol Neurobiol. 2018. PMID: 28466274 Free PMC article. Review.
-
Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.Sci Transl Med. 2013 May 8;5(184):184ra59. doi: 10.1126/scitranslmed.3005365. Sci Transl Med. 2013. PMID: 23658244 Free PMC article.
-
Ultrasound microbubbles combined with liposome-mediated pNogo-R shRNA delivery into neural stem cells.Neural Regen Res. 2012 Jan 5;7(1):54-9. doi: 10.3969/j.issn.1673-5374.2012.01.009. Neural Regen Res. 2012. PMID: 25806059 Free PMC article.
-
Traumatic brain injury: future assessment tools and treatment prospects.Neuropsychiatr Dis Treat. 2008 Oct;4(5):877-92. doi: 10.2147/ndt.s1985. Neuropsychiatr Dis Treat. 2008. PMID: 19183780 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous